G Cartei
Overview
Explore the profile of G Cartei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Cartei G, Colombrino E, Sanzari M, Plebani M, Micucci M, Fiorica F, et al.
J Chemother
. 2012 Jan;
23(6):362-6.
PMID: 22233822
Mitomycin C (MC) is used as therapy against solid tumors, also combined with other chemotherapeutic agents or radiotherapy. It may cause acute, subacute, or chronic anemia capable of modifying the...
3.
Clocchlatti L, Cartei G, Lavaroni A, Vigevani E, Fabrls G, Tommasini G, et al.
Interv Neuroradiol
. 2010 Aug;
2(4):277-81.
PMID: 20682108
Twenty three patients (18 males) were followed from January 1993 to July 1996 for primary central nervous system malignancy: glioblastoma multiforme (GM) (15 patients), anaplastic astrocytoma (AA) (8 patients). Ninety...
4.
Zustovich F, Della Puppa A, Scienza R, Anselmi P, Furlan C, Cartei G
Acta Neurochir (Wien)
. 2008 Jun;
150(7):699-702.
PMID: 18548193
Oligodendroglioma cells are detectable in the cerebro-spinal fluid in up to 14% of patients [10] and cerebellar and/or spinal cord involvement is a well known phenomenon [3]. Distant spread of...
5.
Zustovich F, Lombardi G, Cartei G
J Eur Acad Dermatol Venereol
. 2008 Jun;
23(2):220-1.
PMID: 18540989
No abstract available.
6.
7.
Nicoletto M, Tumolo S, Sorio R, Cima G, Endrizzi L, Nascimben O, et al.
Int J Gynecol Cancer
. 2007 Feb;
17(5):986-92.
PMID: 17316364
The purpose of this study was to compare long-term survival in first-line chemotherapy with and without platinum in advanced-stage ovarian cancer. From July 1987 to November 1992, 161 untreated patients...
8.
Zustovich F, Pavei P, Cartei G
J Eur Acad Dermatol Venereol
. 2006 Jul;
20(6):757-8.
PMID: 16836522
No abstract available.
9.
Cartei G, Binato S, Sacco C, Bearz A, Scalone S, Ceravolo R, et al.
Ann Oncol
. 2006 Jun;
17 Suppl 5:v47-51.
PMID: 16807462
Background: Chemotherapy of non-small-cell lung cancer (NSCLC) has been improved by the use of cis-platin (P) and the pyrimidine antimetabolite gemcitabine (G) (2',2'-difluorodeoxycytidine). GP regimens currently used in Italy for...
10.
Cartei G, Trestin A, Colombrino E, Nadai M, Richter S, Barzon L, et al.
Ann Oncol
. 2006 Jun;
17 Suppl 5:v25-28.
PMID: 16807458
Background: The pyrimidine antimetabolite Gemcitabine (G) (2',2'-difluorodeoxycytidine) is used against several malignancies G exerts its antitumour effect mainly by incorporation of its triphosphate metabolite (dFdCTP) into DNA. Subsequently, DNA polymerase...